yangambin and Liver-Cirrhosis

yangambin has been researched along with Liver-Cirrhosis* in 1 studies

Other Studies

1 other study(ies) available for yangambin and Liver-Cirrhosis

ArticleYear
Lirioresinol B dimethyl ether inhibits NF-κB and COX-2 and activates IκBα expression in CCl
    BMC complementary medicine and therapies, 2020, Feb-11, Volume: 20, Issue:1

    Inflammation is one of the key components in the initiation and progression of hepatic diseases. If not treated, inflammation may cause cell dysplasia, and ultimately cancer. In the current study, we investigated the anti-inflammatory and anti-cancer activities of plant isolated compound Lirioresinol B Dimethyl Ether (LBDE) extracted from the seeds of Magnolia fargesii CHENG (Magnoliaceae) against HepG2 cells as well as in BALB/C male mice.. Intraperitoneal injection of LBDE (50 mg/kg body weight/day) inhibited CCl

    Topics: Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Furans; Hep G2 Cells; Humans; Liver Cirrhosis; Male; Mice; Mice, Inbred BALB C; Molecular Structure; NF-kappa B; NF-KappaB Inhibitor alpha; Plant Extracts; Seeds

2020